Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 26, 2026
TotalEnergies (TTE) Eyes $100 After +40% Year-to-Date Advance

TotalEnergies (TTE) Eyes $100 After +40% Year-to-Date Advance

Key Takeaways

  • Selected price target: $100 per share, a round-number psychological milestone roughly 10% above the latest trading level near $91.
  • Strongest bullish factors: a 12-month analyst consensus of "Buy," an average price target near $97, and several individual targets at or above $100.
  • Biggest risks: volatile commodity prices, heavy reliance on Middle East production, and a rich run-up that leaves the stock near multi-year highs.
  • Key levels: the prior 52-week high around $94 acts as near-term resistance, with support in the mid-to-high $80s.
  • Takeaway: $100 is realistic but not guaranteed — it likely depends on sustained energy prices and continued execution rather than another broad market tailwind.

Why the $100 Level Draws Attention

The $100 threshold is a classic psychological target. TTE has not yet traded at that level on a sustained basis in its recent history, and its 52-week high sits just below $94. Because round numbers tend to attract attention from both retail traders and institutional managers, a decisive move above $100 would signal a genuine breakout from the stock's current trading range — not simply another incremental advance.

Where the Stock Stands Today

TTE carries a market capitalization of roughly $200 billion and trades at a trailing price-to-earnings (P/E) ratio near 11, with a forward P/E below 9 in some estimates. The shares offer a dividend yield of roughly 4.4%, which is notable for a large-cap integrated energy name. A low five-year beta of about 0.06 reflects the stock's historically muted sensitivity to broader market swings, even as its own sector remains highly cyclical.

The recent rally has been powerful: the stock is up more than 50% over the past year. That momentum has pushed TTE to the upper end of its range, which is precisely why the debate over $100 has intensified. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Factors That Could Support Further Gains

TTE benefits from a diversified, "dual-engine" strategy that pairs conventional oil and liquefied natural gas (LNG) with growing investments in electricity and low-carbon power. Rising energy prices — partly fueled by supply concerns around the Strait of Hormuz, a chokepoint for global oil flows — have supported earnings revisions across the sector. Analysts have noted that TotalEnergies derives roughly a quarter of its upstream production from the Middle East, making its financial results sensitive to regional stability but also to any resulting price strength.

Beyond commodity prices, the company's disciplined capital allocation, steady buybacks, and reliable dividend provide a supportive backdrop. An investor day focused on long-term growth could reinforce confidence in the stock's trajectory.

Obstacles That Could Slow the Advance

The clearest obstacle is commodity-price risk. TotalEnergies' profitability is closely tied to crude oil and natural gas prices, and any cooling of the current geopolitical premium could pressure earnings estimates and the stock. A sustained resolution of Middle East supply disruptions, for example, could unwind some of the recent gains.

Valuation discipline among analysts is another factor. While the consensus average target sits near $97, not every firm is equally bullish. JPMorgan recently moved its rating to Neutral with a target near $95, arguing the long-term fundamentals are intact but that near-term cash-flow risks exist around the Strait of Hormuz. Such caution suggests the final leg toward $100 may not come easily.

Analyst Views and Price Targets

The broader analyst community leans positive. The consensus rating is "Buy," with an average 12-month price target around $97 — already within striking distance of $100. Individual targets extend higher: Mizuho initiated coverage with a $103 target, Jefferies maintains a Buy with a $101 target, and TD Cowen reiterates Buy with a target as high as $108. Meanwhile, upgrades from HSBC and UBS reflect raised commodity-price assumptions and a view that higher margins could outpace the impact of regional disruptions.

Collectively, these targets imply that $100 sits comfortably within — or even below — the upper end of the analyst range, lending credibility to the milestone.

Important Technical Levels

From a technical analysis perspective, the stock's 52-week high around $94 represents the first meaningful resistance level to clear. If TTE can hold above that zone, $100 becomes the next logical psychological and round-number target. On the downside, the mid-to-high $80s have served as a support area during recent consolidations, providing a cushion if momentum stalls. From what I see, watching these levels closely helps clarify whether the momentum is sustainable.

Using AI Tools to Track Momentum

In my own research, I occasionally turn to Tickeron’s AI Daily Buy/Sell Signals to monitor whether TTE can sustain its push toward $100. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to spot emerging opportunities, track existing positions, and identify changing market trends more efficiently than manual screening alone. As TTE approaches a key resistance level, keeping an eye on AI-generated signals can help investors gauge whether momentum is strengthening or fading.

Overall Outlook

A move to $100 for TotalEnergies appears realistic given the stock's current level near $91, its favorable analyst consensus, and multiple price targets at or above the century mark. The strongest support comes from resilient energy prices, disciplined shareholder returns, and a diversified growth strategy. However, the path is not without risk: the stock is already near multi-year highs, and its fortunes remain tied to commodity markets and Middle East stability. Investors should monitor crude oil and LNG price trends, any updates around Strait of Hormuz supply risks, and whether TTE can convert its recent momentum into a confirmed breakout above $94 before $100 becomes a realistic near-term objective.

Exploring Tickeron AI Daily Buy/Sell Signals

I find Tickeron’s AI Daily Buy/Sell Signals particularly useful when evaluating names like TTE near key technical thresholds. The platform applies AI to scan market data in real time and deliver actionable signals that complement traditional fundamental and technical work. In practice, this helps me stay objective about whether momentum is building or fading without having to review every chart manually.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TTE

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


TTE sees its Stochastic Oscillator climbs out of oversold territory

On September 24, 2026, the Stochastic Oscillator for TTE moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 40 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where TTE advanced for three days, in 208 of 382 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

The Aroon Indicator entered an Uptrend today. In 188 of 339 cases where TTE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Bearish Trend Analysis

The 10-day RSI Indicator for TTE moved out of overbought territory on August 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 20 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 51%.

The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TTE as a result. In 42 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.

The Moving Average Convergence Divergence Histogram (MACD) for TTE turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 23 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TTE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 27, placing this stock better than average.

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.564) is normal, around the industry mean (1.912). P/E Ratio (11.382) is within average values for comparable stocks, (16.706). Projected Growth (PEG Ratio) (0.822) is also within normal values, averaging (1.091). Dividend Yield (0.043) settles around the average of (0.034) among similar stocks. P/S Ratio (1.013) is also within normal values, averaging (3.764).

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. TTE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 124.76B. The market cap for tickers in the group ranges from 63.2K to 660.33B. XOM holds the highest valuation in this group at 660.33B. The lowest valued company is CRRDF at 63.2K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was -3%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 1%. SHEL experienced the highest price growth at 1%, while SLNG experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was -52%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 52
Price Growth Rating: 43
SMR Rating: 55
Profit Risk Rating: 27
Seasonality Score: 28 (-100 ... +100)
View a ticker or compare two or three
TTE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of oil and gas products

Industry IntegratedOil

Industry
Integrated Oil
Address
2, Place Jean Millier
Phone
+33 147444546
Employees
101513
Web
https://www.totalenergies.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.